T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.07% |
| 2 | Healthcare | 18.73% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.39% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DOOR
1826
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $858K | ﹤0.01% |
12,033
+2,104
| +21% | +$175K |
|
1827
Ezcorp Inc
EZPW
$1.76B
| $853K | ﹤0.01% |
110,574
-4,821
| -4% | -$39.9K |
|
1828
AZZ Inc
AZZ
$4.51B
| $851K | ﹤0.01% |
23,289
-2,452,493
| -99% | -$102M |
|
1829
Cracker Barrel
CBRL
$1.28B
| $851K | ﹤0.01% |
9,182
+1,746
| +23% | +$176K |
|
|
ACH
1830
Accendra Health
ACH
$82.3M
| $851K | ﹤0.01% |
35,289
+1,515
| +4% | +$46.7K |
|
1831
Knowles
KN
$3.31B
| $850K | ﹤0.01% |
69,795
-1,524,246
| -96% | -$24.4M |
|
1832
Modine Manufacturing
MOD
$11B
| $850K | ﹤0.01% |
65,650
+2,957
| +5% | +$41.5K |
|
1833
Adtran
ADTN
$681M
| $849K | ﹤0.01% |
43,344
-7,747
| -15% | -$169K |
|
1834
Stem
STEM
$56.7M
| $845K | ﹤0.01% |
3,167
+614
| +24% | +$157K |
|
1835
Integer Holdings
ITGR
$4.26B
| $844K | ﹤0.01% |
13,550
+2,156
| +19% | +$145K |
|
1836
Tronox
TROX
$961M
| $843K | ﹤0.01% |
68,739
-2,216
| -3% | -$32.9K |
|
1837
Astrana Health
ASTH
$1.91B
| $842K | ﹤0.01% |
21,579
+3,731
| +21% | +$171K |
|
1838
Provident Financial Services
PFS
$3.24B
| $841K | ﹤0.01% |
43,101
+7,154
| +20% | +$167K |
|
1839
Upstart Holdings
UPST
$3B
| $841K | ﹤0.01% |
40,440
-3,166
| -7% | -$85.2K |
|
1840
Benchmark Electronics
BHE
$2.92B
| $839K | ﹤0.01% |
33,823
+4,866
| +17% | +$124K |
|
1841
Nektar Therapeutics
NKTR
$2.52B
| $838K | ﹤0.01% |
17,442
-1,175
| -6% | -$69.9K |
|
1842
LiveRamp
RAMP
$2.31B
| $837K | ﹤0.01% |
46,077
+7,061
| +18% | +$163K |
|
1843
Tompkins Financial
TMP
$1.47B
| $836K | ﹤0.01% |
11,511
+2,054
| +22% | +$154K |
|
|
BBT
1844
Beacon Financial Corp
BBT
$2.7B
| $835K | ﹤0.01% |
30,558
+2,655
| +10% | +$74.1K |
|
|
DNB
1845
DELISTED
Dun & Bradstreet
DNB
| $835K | ﹤0.01% |
67,332
+9,932
| +17% | +$147K |
|
1846
First Busey Corp
BUSE
$2.59B
| $833K | ﹤0.01% |
37,885
+7,459
| +25% | +$177K |
|
1847
LegalZoom.com
LZ
$985M
| $832K | ﹤0.01% |
96,886
-8,186,312
| -99% | -$84.7M |
|
1848
Compass
COMP
$10.2B
| $831K | ﹤0.01% |
357,758
-550,952
| -61% | -$1.96M |
|
1849
Central Garden & Pet Co Class A
CENTA
$2.41B
| $830K | ﹤0.01% |
30,350
+6,347
| +26% | +$199K |
|
|
HAPN
1850
Happen Inc
HAPN
$2.27B
| $830K | ﹤0.01% |
75,038
+9,479
| +14% | +$128K |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.